MCL1 and Miyoshi myopathy: BM mesenchymal stromal cells (BMMSCs) protect MM cells against the lytic activity of MM-reactive CTLs and daratumumab-redirected NK cells through upregulation of the anti-apoptotic proteins Survivin and Mcl-1.